Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.

Acquazzino, Melissa A

Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor. [electronic resource] - Pediatric transplantation Aug 2013 - 466-71 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

1399-3046

10.1111/petr.12101 doi


Anemia, Hemolytic, Autoimmune--etiology
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Calcineurin--metabolism
Cyclophosphamide--therapeutic use
Cyclosporine--therapeutic use
Everolimus
Female
Hemolysis
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppression Therapy--adverse effects
Immunosuppressive Agents--adverse effects
Infant
Intestines--transplantation
Liver Transplantation--adverse effects
Male
Medical Records
Nephrotic Syndrome--etiology
Pancreas Transplantation--adverse effects
Penicillins--therapeutic use
Plasmapheresis
Retrospective Studies
Rituximab
Sirolimus--analogs & derivatives
Steroids--therapeutic use
TOR Serine-Threonine Kinases--antagonists & inhibitors
Tacrolimus--therapeutic use
Transplantation--adverse effects
Treatment Outcome